Stock Recommendations For Your Portfolio

Excel Industries | BSE CODE: 500650 | VOLUME: 16744 | CMP: Rs.297

Excel Industries is engaged in manufacturing and sale of industrial and specialty chemicals, pesticides intermediates, soil enriches bio-pesticides, and other bio-products. In Q1 2015, net profit jumped to Rs 9.95 crore against Rs. 3.1 crore in the corresponding quarter of the previous year, a significant increase of 221.27 per cent. The company’s net sales increased by 18.55 per cent at Rs. 121.33 crore from Rs 102.35 crore over the previous year. Operating profit is Rs 20.72 crore as against Rs 10.44 crore in the corresponding period of the previous year, an increase of 98.54 per cent. The company posted earnings per share of Rs. 9.13 a share during the quarter as against Rs. 2.84 over previous year. Currently, Excel Industries is trading at a TTM PE ratio of 13.3 and on the basis of price to book, it trades at 2.04x.

Granules India | BSE CODE: 532482 | VOLUME: 110212 | CMP: Rs.825

Granules India is a pharma company involved in the manufacture of API, PFI and Finished Dosage (FD). Granules is a fully integrated player offering services from API to formulation manufacturing with more than 90 per cent of its business coming from exports (60 per cent to US and Europe). Granules reported very strong 36.23 per cent on the back on good growth across all segments and with help of Auctus Pharma acquisition. FDs is leading followed by PFIs and then by APIs. Going ahead, by 2016 revenue mix would look like at least about 40 per cent as FDs, may be about 30-35 per cent as PFIs and the rest as APIs. The company has begun working on ANDA filings and aims to file 3 ANDAs within the next 12 months. Overall top line growth expected a minimum of 25 per cent and bottom-line growth will be more than 30-35 per cent.